Promoting and regulating generic medicines: Brazil in comparative perspective.

Area of Science:

• Health Policy
• Pharmaceutical Economics
• Public Health

Background:

• Generic drug promotion is vital for national pharmaceutical policies, aiming to lower drug expenditure and broaden healthcare access.
• Comparative analysis of generic drug policies is hindered by a lack of standardized assessment frameworks.
• Understanding stakeholder interests is crucial for effective policy development and implementation.

Purpose of the Study:

• To establish a comprehensive framework for evaluating and comparing national generic drug policies.
• To identify key dimensions for assessing generic drug policy effectiveness.
• To explore the influence of stakeholder interests on policy formulation and execution.

Main Methods:

• Analysis of national regulations across four critical dimensions: therapeutic equivalence, packaging and labeling, prescription, and substitution.
• Examination of public and private sector stakeholder influences on policy.
• Case study focusing on Brazil to illustrate policy challenges and conflicts.

Main Results:

• Identified four core dimensions for comparative analysis of generic drug policies.
• Highlighted the impact of diverse stakeholder interests on policy implementation.
• Illustrated policy development complexities through the Brazil case study.

Conclusions:

• The proposed framework offers a roadmap for comparative analysis of generic drug policies.
• Addressing stakeholder dynamics is essential for successful generic drug policy implementation.
• Further research can utilize this framework to conduct cross-national policy evaluations.